Experience

Cooley Secures Dismissal With Prejudice for Aurinia Pharmaceuticals

August 13, 2024

Cooley secured a summary judgment with prejudice for Aurinia Pharmaceuticals (Aurinia), a Canada-based company focused on developing therapies to treat autoimmune diseases, in a securities class action challenging numerous public statements made over a period of nine months. The Cooley team was led by securities litigation and enforcement partners Koji Fukumura and Ryan Blair, with support from associates Heather Speers, Matt Martinez and Jessica Taylor. The case is Michael J. Ortmann v. Aurinia Pharmaceuticals, Inc. et al. (Case No.: 22-1335-BAH).

Read more

Related contacts

Koji Fukumura
Partner, San Diego
Ryan Blair
Partner, San Diego
Heather Speers
Partner, San Diego
Matt Martinez
Associate, San Diego
Jessica Taylor
Associate, San Diego

Related Practices & Industries

Admissions and credentials

California

Colorado

North Carolina

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.